Related Experiment Video

Updated: Oct 26, 2025

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.2K

Role of Metastasis Suppressor KAI1/CD82 in Different Cancers

Wei Yan1,2,3, Jinny Huang1, Qian Zhang3

  • 1Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Journal of Oncology
|July 26, 2021
PubMed

Insights

KAI1/CD82 acts as a tumor metastasis suppressor gene. Its reduced expression is linked to poor prognosis, highlighting its potential as a biomarker and therapeutic target for preventing cancer metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Metastasis is a hallmark of malignant tumors and a primary cause of cancer-related mortality.
  • Tumor metastasis is influenced by genes, the microenvironment, and extracellular matrix interactions.
  • Identifying metastasis mechanisms and therapeutic targets is crucial for cancer prevention.

Purpose of the Study:

  • To review the role of KAI1/CD82 in the metastasis of various cancers.
  • To examine KAI1/CD82's potential as a clinical biomarker for tumor progression.
  • To explore KAI1/CD82 as a therapeutic target for preventing cancer metastasis.

Main Methods:

  • Literature review of studies on KAI1/CD82 and cancer metastasis.
  • Analysis of KAI1/CD82's interactions with other molecules (tetraspanins, integrins).
  • Evaluation of KAI1/CD82's impact on cell motility, adhesion, and apoptosis.

Main Results:

  • KAI1/CD82 functions as a tumor metastasis suppressor gene across different cancer types.
  • Low KAI1/CD82 expression correlates with poor patient prognosis.
  • KAI1/CD82 regulates critical metastatic processes including cell motility and adhesion.

Conclusions:

  • KAI1/CD82 is a significant factor in controlling tumor metastasis.
  • KAI1/CD82 holds promise as a predictive biomarker for cancer progression.
  • Targeting KAI1/CD82 presents a potential therapeutic strategy for combating cancer metastasis.

More Related Videos

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

2.8K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.8K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K